World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 2, Number 5, October 2011, pages 245-251


“Short Course” of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)

Tables

Table 1. Characteristics of Patients
 
PatientsNumbers/value of characteristics
*Fluorescence In-Situ Hybridation not amplified.
Total30
Age (median)58.5 (31-73)
Baseline stage
  IIA6
  IIB4
  IIIA11
  IIIB9
Menopausal Status
  Post18
  Pre12
Hormonal Receptor
  EgR positive25
  EgR negative5
  EgR/PgR negative4
HER2-status
  09
  19
  25*
  37

 

Table 2. Response
 
Number of patientsPercentage (%)
Complete response827
Partial response1033
Minimal response413
Stable disease724
Progressive disease13
pCR13
No residual tumor on breast26

 

Table 3. Toxicity
 
Gr. 2Gr. 3Gr. 4
*1 febrile neutropenia.
Neutropenia510*3*
Anemia100
Nausea800
Vomiting010
Joint symptoms310
Asthenia010
Diarrhoea100
Neuropathy200
Hepatotoxicity400